Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DAS Group of Companies is an Omnicom-owned global marketing services organization rather than a drug developer, biotech, or healthcare operating company. The group includes more than 200 companies spanning specialty marketing, public relations, healthcare communications, CRM, events, branding, and research. Within the portfolio, healthcare activity appears to be concentrated in Omnicom Health Group and related communications businesses serving pharmaceutical and healthcare clients. DAS operates internationally through a network model and has been described as serving clients through hundreds of offices worldwide. For biotech analyst purposes, DAS is best understood as a commercial services and communications holding organization with healthcare exposure, not a therapeutic pipeline company.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DAS Group of Companies.